Follow
Min-Han Tan
Min-Han Tan
Lucence Health
Verified email at lucence.com
Title
Cited by
Cited by
Year
Patterns of somatic mutation in human cancer genomes
C Greenman, P Stephens, R Smith, GL Dalgliesh, C Hunter, G Bignell, ...
Nature 446 (7132), 153, 2007
34152007
Lifetime Cancer Risks in Individuals with Germline PTEN Mutations
MH Tan, JL Mester, J Ngeow, LA Rybicki, MS Orloff, C Eng
Clinical Cancer Research 18 (2), 400-407, 2012
8362012
External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study
DYC Heng, W Xie, MM Regan, LC Harshman, GA Bjarnason, ...
The lancet oncology 14 (2), 141-148, 2013
8342013
Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors
H Li, ET Courtois, D Sengupta, Y Tan, KH Chen, JJL Goh, SL Kong, ...
Nature genetics 49 (5), 708, 2017
6372017
An Antioxidant Response Phenotype Shared between Hereditary and Sporadic Type 2 Papillary Renal Cell Carcinoma
A Ooi, JC Wong, D Petillo, D Roossien, V Perrier-Trudova, D Whitten, ...
Cancer Cell 20 (4), 511-523, 2011
3692011
A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands
MH Tan, J Mester, C Peterson, Y Yang, JL Chen, LA Rybicki, K Milas, ...
The American Journal of Human Genetics 88 (1), 42-56, 2011
3472011
Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins
PH Tan, AA Thike, WJ Tan, MMM Thu, I Busmanis, HH Li, WY Chay, ...
Journal of clinical pathology, jclinpath-2011-200368, 2011
2712011
Changing epidemiology of oral squamous cell carcinoma of the tongue: A global study
JH Ng, NG Iyer, MH Tan, G Edgren
Head & neck 39 (2), 297-304, 2017
2472017
A molecular classification of papillary renal cell carcinoma
XJ Yang, MH Tan, HL Kim, JA Ditlev, MW Betten, CE Png, EJ Kort, ...
Cancer Research 65 (13), 5628-5637, 2005
2392005
Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma
MH Tan, C Morrison, P Wang, X Yang, CJ Haven, C Zhang, P Zhao, ...
Clinical cancer research 10 (19), 6629-6637, 2004
2372004
Metastatic non–clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database …
N Kroeger, W Xie, JL Lee, GA Bjarnason, JJ Knox, MJ MacKenzie, ...
Cancer 119 (16), 2999-3006, 2013
1962013
Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapy
DY Heng, MJ Mackenzie, UN Vaishampayan, GA Bjarnason, JJ Knox, ...
Annals of Oncology 23 (6), 1549-1555, 2011
1442011
Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials
DYC Heng, TK Choueiri, BI Rini, J Lee, T Yuasa, SK Pal, S Srinivas, ...
Annals of Oncology 25 (1), 149-154, 2014
1382014
Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study
LC Harshman, W Xie, GA Bjarnason, JJ Knox, M MacKenzie, L Wood, ...
The Lancet Oncology 13 (9), 927-935, 2012
1352012
Label-free isolation of circulating tumor cells in microfluidic devices: Current research and perspectives
I Cima, C Wen Yee, FS Iliescu, W Min Phyo, K Hon Lim, C Iliescu, ...
Biomicrofluidics 7 (1), 011810, 2013
1332013
Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype
CJ Haven, VM Howell, PHC Eilers, R Dunne, M Takahashi, ...
Cancer research 64 (20), 7405-7411, 2004
1202004
Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma
B Gardie, A Remenieras, D Kattygnarath, J Bombled, S Lefèvre, ...
Journal of medical genetics 48 (4), 226-234, 2011
1052011
Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications
X Yao, CN Qian, ZF Zhang, MH Tan, EJ Kort, XJ Yang, JH Resau, BT Teh
Clinical cancer research 13 (1), 161-169, 2007
1012007
Identification of MEN1 and HRPT2 somatic mutations in paraffin‐embedded (sporadic) parathyroid carcinomas
CJ Haven, M Van Puijenbroek, MH Tan, BT Teh, GJ Fleuren, T Van Wezel, ...
Clinical endocrinology 67 (3), 370-376, 2007
1002007
Prognostic factors in patients with diffuse large B cell lymphoma: before and after the introduction of rituximab
L Ngo, SW Hee, LC Lim, M Tao, R Quek, SP Yap, EL Loong, I Sng, ...
Leukemia & lymphoma 49 (3), 462-469, 2008
982008
The system can't perform the operation now. Try again later.
Articles 1–20